| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040722741 |
| P356 | DOI | 10.1186/BCR2466 |
| P932 | PMC publication ID | 2880421 |
| P698 | PubMed publication ID | 20056007 |
| P5875 | ResearchGate publication ID | 40893993 |
| P50 | author | Anne-Lise Børresen-Dale | Q11958220 |
| Ida R K Bukholm | Q114329374 | ||
| Jo Anders Rønneberg | Q114575649 | ||
| Florence Busato | Q117267002 | ||
| Vessela Kristensen | Q37344701 | ||
| Fredrik Wärnberg | Q38155358 | ||
| Jorg Tost | Q41047855 | ||
| Therese Sørlie | Q60034610 | ||
| Hiroko Kato Solvang | Q91221539 | ||
| Jovana Jovanović | Q91418504 | ||
| P2093 | author name string | Johan Botling | |
| Aslaug Aa Muggerud | |||
| P2860 | cites work | Validation of reference genes for quantitative RT-PCR studies in porcine oocytes and preimplantation embryos | Q21284136 |
| PTEN: life as a tumor suppressor | Q28203431 | ||
| A gene hypermethylation profile of human cancer | Q28213253 | ||
| The epigenomics of cancer | Q28289975 | ||
| Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up | Q28306437 | ||
| Genomic and transcriptional aberrations linked to breast cancer pathophysiologies | Q29619120 | ||
| Quantitative assessment of promoter hypermethylation during breast cancer development | Q30811494 | ||
| Molecular markers in ductal carcinoma in situ of the breast. | Q31135997 | ||
| Gene expression profiles of human breast cancer progression | Q33186821 | ||
| Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis | Q33243821 | ||
| Fox's in development and disease | Q34205134 | ||
| DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma | Q34274795 | ||
| Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype | Q34975498 | ||
| Classification of ductal carcinoma in situ by gene expression profiling | Q35605885 | ||
| Frequent 7q gains in flow cytometric multiploid/hypertetraploid breast carcinomas: a study of chromosome imbalances by comparative genomic hybridisation | Q35769900 | ||
| p53 mutations and expression in breast carcinoma in situ | Q35793421 | ||
| Correlation between CpG methylation profiles and hormone receptor status in breast cancers | Q36393321 | ||
| Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. | Q36787353 | ||
| Cell type-specific DNA methylation patterns in the human breast | Q36869180 | ||
| The molecular journey from ductal carcinoma in situ to invasive breast cancer | Q37126345 | ||
| Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis | Q37268177 | ||
| Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells | Q39918721 | ||
| Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression | Q40291730 | ||
| Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. | Q40550191 | ||
| Ductal carcinoma in situ: a proposal for a new classification | Q40576913 | ||
| Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer | Q40626135 | ||
| Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution | Q41130119 | ||
| GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. | Q42439010 | ||
| Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer | Q42499457 | ||
| Mismatch repair genes hMLH1 and hMSH2 may not play an essential role in breast carcinogenesis | Q42516388 | ||
| Integrated profiling of basal and luminal breast cancers. | Q42522755 | ||
| MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine | Q44807704 | ||
| Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells. | Q45232200 | ||
| Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors | Q45877410 | ||
| In situ analyses of genome instability in breast cancer | Q46051522 | ||
| Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer | Q46172041 | ||
| Selection of reference genes for quantitative real-time RT-PCR studies in mouse brain. | Q46943029 | ||
| Mapping of ER gene CpG island methylation-specific polymerase chain reaction | Q47945083 | ||
| Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. | Q53342403 | ||
| Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia | Q53429823 | ||
| Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis | Q53530745 | ||
| Methylation of E-cadherin and hMLH1 genes in Indian sporadic breast carcinomas. | Q54617735 | ||
| Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma | Q57161281 | ||
| p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast | Q73828802 | ||
| Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR | Q73852496 | ||
| Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients | Q78794145 | ||
| GSTP1 promoter hypermethylation is an early event in breast carcinogenesis | Q80265741 | ||
| Promoter methylation of the PTEN gene is a common molecular change in breast cancer | Q80403566 | ||
| PTEN promoter is methylated in a proportion of invasive breast cancers | Q80594418 | ||
| Expression of mismatch repair proteins in invasive and in situ carcinoma of the breast | Q80954893 | ||
| DNA methylation analysis by pyrosequencing | Q81247006 | ||
| P433 | issue | 1 | |
| P921 | main subject | breast cancer | Q128581 |
| DNA methylation | Q874745 | ||
| ductal carcinoma | Q5311598 | ||
| P304 | page(s) | R3 | |
| P577 | publication date | 2010-01-07 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer | |
| P478 | volume | 12 |
| Q58597281 | A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA |
| Q34447578 | ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth |
| Q38617799 | All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase |
| Q60961798 | Analysis of PTEN expression and promoter methylation in Uyghur patients with mild type 2 diabetes mellitus |
| Q34709370 | Assessment of DNA methylation status in early stages of breast cancer development |
| Q42371780 | Association between MGMT Promoter Methylation and Risk of Breast and Gynecologic Cancers: A Systematic Review and Meta-Analysis. |
| Q41012393 | Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran |
| Q41056167 | BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer |
| Q63245336 | CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers |
| Q34294336 | Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. |
| Q36778107 | Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors. |
| Q38692509 | CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer. |
| Q64940251 | DNA Methylation Profiles and Their Diagnostic Utility in BC. |
| Q37308097 | DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study |
| Q33952447 | DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. |
| Q36998647 | DNA methylation in ductal carcinoma in situ of the breast |
| Q35888926 | DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer |
| Q38610743 | Diagnostic and prognostic epigenetic biomarkers in cancer |
| Q47400654 | Distinct B subunits of PP2A regulate the NF-κB signalling pathway through dephosphorylation of IKKβ, IκBα and RelA. |
| Q46699535 | Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis |
| Q58595841 | Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing |
| Q38696796 | Ductal carcinoma in situ - update on risk assessment and management |
| Q33656372 | Effects on specific promoter DNA methylation in zebrafish embryos and larvae following benzo[a]pyrene exposure |
| Q53262835 | Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer |
| Q37865530 | Epigenetic regulation of drug processing genes |
| Q39311503 | Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1. |
| Q38042440 | Epigenetic-dependent regulation of drug transport and metabolism: an update |
| Q35190483 | Epigenetics in breast and prostate cancer |
| Q49624286 | FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles |
| Q34543873 | FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer |
| Q39564479 | FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells |
| Q39176111 | FOXC1: an emerging marker and therapeutic target for cancer |
| Q90613095 | Forkhead box C1 promotes metastasis and invasion of non-small cell lung cancer by binding directly to the lysyl oxidase promoter |
| Q28505995 | Forkhead box transcription factor FoxC1 preserves corneal transparency by regulating vascular growth |
| Q36476460 | FoxC1-Dependent Regulation of Vascular Endothelial Growth Factor Signaling in Corneal Avascularity |
| Q34196315 | Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis |
| Q36096510 | Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer |
| Q44573227 | Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors. |
| Q35871547 | Hormone Replacement Therapy Associated White Blood Cell DNA Methylation and Gene Expression are Associated With Within-Pair Differences of Body Adiposity and Bone Mass |
| Q33556583 | Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients |
| Q38848220 | Identification of genes associated with renal cell carcinoma using gene expression profiling analysis |
| Q34066320 | Integrating multi-omics for uncovering the architecture of cross-talking pathways in breast cancer |
| Q47805346 | Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors |
| Q49680751 | Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer |
| Q34876968 | MCT-1 expression and PTEN deficiency synergistically promote neoplastic multinucleation through the Src/p190B signaling activation |
| Q35169101 | Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells. |
| Q33577711 | Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations |
| Q35000210 | Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features |
| Q38503758 | Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer |
| Q26775086 | MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer |
| Q93108431 | MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer |
| Q36827700 | MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer |
| Q37376285 | Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation |
| Q36796453 | PP2A Counterbalances Phosphorylation of pRB and Mitotic Proteins by Multiple CDKs: Potential Implications for PP2A Disruption in Cancer |
| Q28088747 | PP2A: The Wolf in Sheep's Clothing? |
| Q53449089 | Promoter CpG island hypermethylation during breast cancer progression |
| Q87641396 | Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma |
| Q37687390 | Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. |
| Q39023899 | Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast. |
| Q49380019 | Protein interactomes of protein phosphatase 2A B55 regulatory subunits reveal B55-mediated regulation of replication protein A under replication stress |
| Q35008011 | Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors |
| Q55496828 | Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program. |
| Q64245323 | The Diverse Consequences of Deregulation in Cancer |
| Q35687321 | The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain |
| Q37251018 | The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review |
| Q37261822 | The association of PTEN hypermethylation and breast cancer: a meta-analysis |
| Q37772356 | The epigenetics of breast cancer |
| Q43914090 | The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia. |
| Q34088277 | The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer |
| Q47327040 | Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer. |
| Q60529799 | Validation of DNA promoter hypermethylation biomarkers in breast cancer — a short report |
| Q90710834 | Whole-Exome Sequencing Analysis of the Progression from Non-Low Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma |
| Q36795811 | Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival. |
| Q47142555 | microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis |
Search more.